Peer-Reviewed Journal Details
Mandatory Fields
O'Hanlon DM, Kerin MJ, Kent P, Maher D, Grimes H, Given HF.
1995
June
British Journal Of Cancer
An evaluation of preoperative CA 15-3 measurement in primary breast carcinoma.
Published
()
Optional Fields
BREAST NEOPLASIA CA 15-3 TUMOR MARKER MONOCLONAL-ANTIBODIES CANCER PATIENTS ANTIGEN LEVELS CA15-3 TUMORS DF3
71
6
1288
1291
In this study of 500 patients with breast carcinoma, we have prospectively assessed the role of preoperative CA 15-3 as a marker of disease burden over a 7 year period. CA 15-3 levels at presentation correlate with stage of disease, tumour size, lymph node status, the presence of metastases and lymphocyte infiltration into the tumour. CA 15-3 alone is not an independent prognostic indicator, although a serum level of > 40 U ml(-1) has a positive predictive value of 83% for the presence of advanced disease. We recommend the routine use of this marker in the preoperative assessment of primary breast carcinoma.
Grant Details
Publication Themes